OLMALINC and prostate carcinoma: LINC00263 was highly expressed in tumor tissues in prostate cancer (P = 0.005) (Fig. 5q) but had no significant effect on survival prognosis (P = 0.977) (Fig. 5r), which may be related to the 10-year survival rate of prostate cancer of over 90%.